Delivery Order SPE2DB20D2002-SPE2DB20FL04E
- Not listed
- This federal contract award, valued at $1,748.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract covers the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
- This federal contract award, valued at $1,227.89, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract covers the provision of a broad range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award, valued at $1,728.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order awarded under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), which has a potential value of up to $999,999,999.00 and runs through November 2026. Through this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award, valued at $1,772.68, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for a delivery order to provide pharmaceutical products and medical supplies as part of the DLA Troop Support Medical Indefinite Delivery Contract (IDC), which is valued at up to $999,999,999.00 and runs through November 2026. The contract covers a wide range of essential medical commodities, including specialty...
- This federal contract award, valued at $1,307.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract provides for the delivery of a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other...
- This federal contract award, valued at $18,378.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract, valued at up to $4,718.79, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. The contract covers a wide range of essential medical commodities,...
- This federal contract award, valued at $7,796.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract provides for the delivery of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award, valued at $97,354.84, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order that falls under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name...
- This federal contract award, valued at $1,433.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines,...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB20FL04EDelivery Order
This federal contract award, valued at $1,067.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order for pharmaceutical and medical supplies to support the DLA Troop Support Medical program, which provides healthcare products to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract covers a broad range of medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical supplies across various therapeutic areas. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract was awarded without any set-aside designations, indicating open competition. In addition to the DLA contract, Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/21/20 |